# HeartGuard Patient Risk Assessment Report

**Patient ID:** 63
**Report Date:** 2026-01-25 13:37

---

## Patient Demographics
- **Age:** 30.0 years
- **Sex:** Male

## ECG Analysis Summary
- **Diagnoses detected:** ASMI, ABQRS, SR
- **ECG Risk Score:** 3/3

## Clinical Profile

### Vital Signs
- Blood Pressure: 102.0/66.0 mmHg
- Resting Heart Rate: 72.0 bpm

### Laboratory Values
- Total Cholesterol: 189.0 mg/dL
- LDL Cholesterol: 113.0 mg/dL
- HDL Cholesterol: 42.0 mg/dL
- Fasting Glucose: 85.0 mg/dL
- HbA1c: 4.7%

## Risk Assessment
- **Overall Risk Category:** High
- **Composite Risk Score:** 0.68 (0-1 scale)
- **Model Prediction:** Low (1)

## Intervention Plan

### Immediate Actions
- **[CRITICAL]** Urgent cardiology evaluation
  - *Reason:* Myocardial infarction pattern detected

### Medication Recommendations
- Dual antiplatelet therapy (aspirin + P2Y12 inhibitor)
  - *Reason:* Secondary prevention post-MI
- High-intensity statin therapy
  - *Reason:* LDL reduction for secondary prevention
- Statin therapy for LDL reduction
  - *Reason:* LDL cholesterol elevated (113.0 mg/dL)

### Lifestyle Modifications
- Cardiac rehabilitation program
- Mediterranean diet and increased soluble fiber
- Moderate aerobic exercise (150 min/week)

### Monitoring Schedule
- Regular cardiovascular follow-up (every 3-6 months)

## Risk Projection
- **Current Risk Score:** 0.684
- **Projected Risk (with interventions):** 0.416
- **Expected Reduction:** 39.2%

### Expected Impact by Intervention
- Statin therapy: 25% relative reduction
- Diet modification: 10% relative reduction
- Exercise program: 10% relative reduction

---

*This report is generated by HeartGuard AI and should be reviewed by a qualified healthcare professional.*

*Synthetic clinical data used for demonstration purposes.*